Why Scotts Miracle-Gro is on investors’ radar

Scotts Miracle-Gro (SMG) has drawn attention after its recent trading performance, with the stock showing mixed returns over the past week, month and past 3 months. This has prompted investors to reassess the lawn and garden specialist.

At a share price of $62.34, Scotts Miracle-Gro has a modest 30 day share price return of 1.43% but a weaker 90 day share price return of a 6.03% decline. Its 1 year total shareholder return of 17.65% contrasts with a 67.30% total shareholder return decline over 5 years, which suggests recent momentum has improved from a much tougher longer term period.

If you are reassessing your portfolio after watching SMG, it can be useful to scan beyond consumer gardening stocks and uncover 18 top founder-led companies

With the stock trading at $62.34, an implied intrinsic discount of 35.41%, and a 19.51% gap to the latest analyst price target, the key question is whether Scotts Miracle-Gro is genuinely undervalued or if the market is already pricing in future growth.

Most Popular Narrative: 43.3% Overvalued

According to the most followed narrative, Scotts Miracle-Gro’s fair value estimate of $43.49 sits well below the recent $62.34 share price. This gap puts a spotlight on the assumptions behind that valuation difference.

SMG’s current valuation reflects lingering skepticism: concerns over cannabis demand, consumer spending softness, and execution risk. But it may also underappreciate the company’s positioning within professional cultivation.

The fair value estimate depends on how far earnings can recover from a very weak five year stretch, how much of that recovery is reflected in margins, and what multiple investors are willing to pay for a cultivation focused model. The tension between recent earnings momentum and slower forecast growth is central to this narrative, and the detailed numbers behind that trade off sit inside the full story.

Result: Fair Value of $43.49 (OVERVALUED)

However, this cultivation focused story could be knocked off course if cannabis demand stays weak or if consumer lawn and garden spending softens again.

Another View: Cash Flows Tell a Different Story

While the most followed narrative sees Scotts Miracle-Gro as 43.3% overvalued at $62.34 versus a $43.49 fair value estimate, the SWS DCF model points the other way. In this view, the stock trades below an estimated future cash flow value of $96.51, raising the question of which set of assumptions you trust more.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Scotts Miracle-Gro for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 51 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With sentiment clearly mixed, now is a good time to review the underlying data yourself and decide how the trade off between growth and valuation stacks up in your view, starting with 4 key rewards and 1 important warning sign.

Ready to hunt for more investment ideas?

If Scotts Miracle-Gro has you thinking differently about risk, reward and valuation, now is the moment to broaden your watchlist using focused stock screens.

• Target potential upside by scanning for companies that combine quality, fundamentals and attractive pricing using the 51 high quality undervalued stocks.
• Prioritise resilience by zeroing in on companies that keep risk scores in check and balance sheets in focus via the 72 resilient stocks with low risk scores.
• Spot under followed opportunities before others by searching through a screener containing 23 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.